The combination of these effects contributes to the highly significant and durable reductions in HbA1c and FPG observed [ 54 ].
← all excerpts
Effect of oral semaglutide on cardiometabolic risk factors in overweight and obese individuals with or without diabetes: a systematic review and meta-analysis.
1
—
—